Biologic

Results: 1831



#Item
441

CDER Biosimilar Biologic INDs with Activity Report[removed]

Add to Reading List

Source URL: www.fda.gov

    442Food and Drug Administration / Cell biology / Center for Biologics Evaluation and Research / Biologic / Stem cell / Bioinformatics / Biology / Biotechnology / Pharmacology

    Center for Biologics Evaluation and Research FDA Overview Regulatory Science Program and Priorities Carolyn A. Wilson, Ph.D.

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    443Chemistry / Science / Pharmaceutical industry / Clinical research / Validity / Center for Biologics Evaluation and Research / Biologic License Application / Validation / Biologic / Food and Drug Administration / Pharmaceutical sciences / Pharmacology

    DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]MEMORANDUM Date:

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    444Pharmacology / Food and Drug Administration / Pharmaceutical industry / Clinical Data Management / Electronic Common Technical Document / Validation / Center for Biologics Evaluation and Research / Biologic / Vaccine / Research / Medicine / Clinical research

    (System Info[removed]SMITH MICHAEL[removed]:48:05 SMITHM) RECORD OF TELEPHONE CONVERSATION Submission Type: BLA Submission ID: [removed]

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    445Clinical research / Food and Drug Administration / Center for Biologics Evaluation and Research / Influenza / Wyeth / Biologic / Vaccine / Email / Biotechnology / Medicine / Pharmacology

    (System Info[removed]SMITH MICHAEL[removed]:44:31 SMITHM) RECORD OF TELEPHONE CONVERSATION Submission Type: BLA Submission ID: [removed]

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    446Pharmacology / Chronic obstructive pulmonary disease / Smoking / Infliximab / Hepatitis / Health / Immunosuppressants / Medicine

    The Role of Biologic Therapies in Emerging Infections Session 13: Health Care Associated Emerging Infections November 2, 2014 John W. Baddley, MD, MSPH University of Alabama at Birmingham

    Add to Reading List

    Source URL: imed.isid.org

    Language: English - Date: 2014-12-02 17:19:45
    447Health / Biologic / Rheumatology / Food and Drug Administration / Medicare / Pharmaceutical drug / Biosimilar / Pharmacology / Pharmaceutical sciences / Clinical research

    Liz Richter, Acting Director Center for Medicare April 21, 2014 Page 1 April 21, 2014

    Add to Reading List

    Source URL: www.rheumatology.org

    Language: English
    448Biotechnology / Medicine / Glycoproteins / Monoclonal antibody therapy / Monoclonal antibodies / Merck & Co. / Biologic / Antibody / Symphogen / Biology / Immune system / Immunology

    [removed]Zymeworks_Merck_Expansion_Extension

    Add to Reading List

    Source URL: www.biotech.ca

    Language: English - Date: 2014-12-09 09:56:32
    449Medicine / Epidemiology / Rare disease / European Federation of Pharmaceutical Industries and Associations / Pharmaceutical industry / Chronic / Biologic / Pharmaceutical drug / European Medicines Agency / Pharmacology / Health / Pharmaceutical sciences

    EUROPABIO_BROCHURE_rare_diseases_EUROPABIO

    Add to Reading List

    Source URL: www.europabio.org

    Language: English - Date: 2014-09-11 08:19:54
    450Drugs / Biologic / Becquerel / Clinical research / Pharmacology / Measurement / Biosimilar / Biotechnology

    WHO BQ Proposal EGA’s perspective 59th INN Consultation WHO, Geneva, October 14th, 2014 Joerg Windisch, PhD Chair, European Biosimilars Group (EBG), an EGA sector group

    Add to Reading List

    Source URL: www.egagenerics.com

    Language: English - Date: 2014-12-27 09:47:29
    UPDATE